West Bengal, India

Arindam Talukdar

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Oncotherapy Science, Incorporated. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arindam Talukdar. Retrieved from https://idiyas.com/inventor/arindam-talukdar-189o2zkt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arindam Talukdar: Innovator in Bicyclic Compounds

Introduction

Arindam Talukdar is a notable inventor based in West Bengal, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Arindam holds a patent for a bicyclic compound that is used for inhibiting SUV39H2. This invention is represented by a specific formula and aims to provide new avenues for treatment in various medical conditions.

Career Highlights

Arindam Talukdar is currently associated with Oncotherapy Science, Incorporated, where he applies his expertise in drug development. His work focuses on creating innovative solutions that can potentially improve patient outcomes.

Collaborations

Some of his notable coworkers include Yo Matsuo and Shoji Hisada, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Arindam Talukdar's work in the field of bicyclic compounds exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for advancements in therapeutic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…